Gray-Market Retatrutide Linked to Reduced Efficacy and Increased Cardiovascular Risks | Retatrutide News

Gray-market retatrutide shows less weight loss efficacy and more cardiovascular effects than expected. This highlights the risks associated with unregul...
Market News · October 19, 2026